Does low total testosterone lead to lower free and bioavailable testosterone?

In clinical endocrinology, testosterone circulates in a dynamic equilibrium where the total pool dictates the absolute ceiling for biologically active fractions. For women, particularly in postmenopausal stages, this relationship is fundamental to understanding androgen status.

Clinical and effectiveness evidence

In women, the total testosterone (TT) pool is significantly smaller than in men, typically ranging from 15 to 70 ng/dL. Research indicates that as women age, TT levels decline by approximately 50% by age 70 compared to their levels in their 20s.

• Correlation data: Studies show a strong positive correlation (r > 0.80) between total and free testosterone levels in postmenopausal populations.
• Bioavailable fractions: Because the free (~1–2%) and bioavailable (free + albumin-bound, ~33%) fractions are subsets of the total, a low total concentration mathematically limits the potential concentration of these fractions.

Mechanistic explanations

The distribution of testosterone is governed by its binding affinity to carrier proteins. In the female circulation, approximately 66% of testosterone is bound with high affinity to Sex Hormone-Binding Globulin (SHBG), while roughly 33% is weakly bound to albumin.

• The "Double Hit" of aging: For a 73-year-old female, the relationship is further strained by age-related increases in SHBG. Post-menopause, SHBG levels often rise by 20–30%.
• Sequestration: When total testosterone is low, a higher SHBG concentration acts to sequester a larger percentage of the remaining hormone. This means that a reduction in the total pool does not just lead to a proportional drop in free testosterone, but often a disproportionately larger decrease because the high-affinity binding sites of SHBG are not saturated.

Bottom line

• Because free and bioavailable testosterone are derived directly from the total circulating pool, a low total testosterone level almost universally results in lower active fractions, a trend exacerbated in older women by rising SHBG levels.